Page 4 - CRM Bulletin Issue 15

IN THE NEWS

Bringing Malaysia to Boston at DIA 2018 Annual Meeting
Boston, 24 – 28 June 2018 – Clinical Research Malaysia was present
at the DIA Annual Conference in Boston to highlight to the
international audience on Malaysia’s capability and achievements in
industry-sponsored research. Besides exhibiting at the booth, the
team at CRM had the opportunity to visit Novartis Institute of
Biomedical Research and were updated on some of the innovations
that are going on at Novartis. The team also visited Karyopharm
Therapeutics Inc. headquarters in Newton, MA, and met with their
amazing leadership team led by Sharon.

Nurturing New Talents in ISR: Endocrinology

PUTRAJAYA, 25 July 2018 – A Talk Series on Nurturing New Talents in Industry Sponsored Research focusing
on endocrinology was held at Hospital Putrajaya with the aim to develop and grow the pool of investigators
in clinical research. The half-day event was well attended by over 30 participants comprising of doctors and
nurses. Among the topics covered include the basics of clinical research, best practices and expectations
towards investigators in clinical trials. Dr. Zanariah Hussein (Heald of Medical Department, Hospital Putrajaya)
and Dr. Shweta Uppal (Head of Clinical, Medical, Regulatory and Quality at Novo Nordisk) were among the
speakers on that day.

Connecting with the Koreans in Digital Health
SEOUL, 29 July-1 August 2018 – The
Director-General of Health Malaysia, Datuk Dr.
Noor Hisham Abdullah and the CRM team had a
series of business networking meetings with the
local Korean sponsors and Korean Government
Agencies in Seoul, Korea. Meetings were also held
with the Korean Healthcare Industry Development
Institute (KHIDI), KoreaBio, Bioinfra Life Science, JK
Medical Group, GeneOne Life Science, SK
Chemical and Genexine. These meetings were
made possible by CRM’s counterpart, C&R
Research Inc., a leading contract research
organization in South Korea. The Koreans exhibited
and demonstrated various digital health
innovations that will change the future of healthcare
in significant ways. Through these meetings, CRM
promoted Malaysia’s clinical research capabilities
and encouraged Korean pharmaceutical companies
to conduct clinical trials in Malaysia.

4 l www.clinicalresearch.my